Please enable JavaScript to continue using this application.

Compare $ANIX vs $OKUR | Chartloom

Compare

$ANIX vs $OKUR

Anixa Biosciences Inc · Onkure Therapeutics Inc

ANIX

Anixa Biosciences Inc

OKUR

Onkure Therapeutics Inc

Compare $ANIX vs $OKUR

Comparing Anixa Biosciences Inc and Onkure Therapeutics Inc

ANIXAnixa Biosciences Inc

OKUROnkure Therapeutics Inc

ANIXAnixa Biosciences Inc

Market cap

$99M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-8.2%

52W performance

-34.7%

FCF yield

-7.5%

OKUROnkure Therapeutics Inc

Market cap

$97M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

71.59x

Rev growth (TTM)

—

YTD performance

-18.6%

52W performance

-20.7%

FCF yield

-49.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ANIX

OKUR

Detailed metrics comparison

ANIX

Anixa Biosciences Inc

OKUR

Onkure Therapeutics Inc

Market Cap

ANIX$99M

OKUR$97M

Enterprise Value

ANIX$97M

OKUR$-69M

Price

ANIX$2.90

OKUR$2.41

P/E Ratio

ANIXN/A

OKURN/A

P/S Ratio

ANIX488.35x

OKUR0.00x

EV/Sales

ANIX481.69x

OKUR0.00x

EV/EBITDA

ANIX0.00x

OKUR0.00x

P/B Ratio

ANIX7.09x

OKUR0.60x

P/FCF Ratio

ANIXN/A

OKURN/A

EV/FCF

ANIX-13.19x

OKUR1.44x

PEG Ratio

ANIXN/A

OKURN/A

Forward P/E (NTM)

ANIXN/A

OKURN/A

Forward P/S (NTM)

ANIXN/A

OKUR71.59x

Revenue (TTM)

ANIX$0

OKUR$0

Revenue Growth (YoY)

ANIXN/A

OKURN/A

Forward Rev Growth

ANIX139.6%

OKUR100.0%

Gross Margin (TTM)

ANIX100.0%

OKUR0.0%

Operating Margin (TTM)

ANIX0.0%

OKUR0.0%

EBITDA Margin (TTM)

ANIX0.0%

OKUR0.0%

Net Margin (TTM)

ANIX0.0%

OKUR0.0%

FCF Margin (TTM)

ANIXN/A

OKURN/A

Net Income (TTM)

ANIX$-10M

OKUR$-59M

FCF (TTM)

ANIX$-7M

OKUR$-48M

EPS (TTM)

ANIX-$0.30

OKUR-$1.18

ROE (TTM)

ANIX-7017.0%

OKUR-4902.0%

ROA (TTM)

ANIX-6780.0%

OKUR-4577.0%

ROIC (TTM)

ANIX-7017.0%

OKUR-4902.0%

Cash

ANIX$1M

OKUR$167M

Debt

ANIX$0

OKUR$0

Net Cash/Debt

ANIX$1M

OKUR$167M

Current Ratio (TTM)

ANIX8.55x

OKUR26.75x

Quick Ratio (TTM)

ANIX7.95x

OKUR26.55x

Debt/Equity (TTM)

ANIX0.00x

OKUR0.00x

Debt/Assets (TTM)

ANIX0.0%

OKUR0.0%

Interest Coverage (TTM)

ANIXN/A

OKURN/A

Net Debt/EBITDA (TTM)

ANIX0.00x

OKUR0.00x

Beta

ANIX0.47

OKUR0.19

52W Performance

ANIX-34.7%

OKUR-20.7%

YTD Performance

ANIX-8.2%

OKUR-18.6%

% from 52W High

ANIX-46.9%

OKUR-55.2%

% from 52W Low

ANIX25.0%

OKUR13.1%

Asset Turnover (TTM)

ANIX0.01x

OKUR0.00x

FCF Yield (TTM)

ANIX-7.5%

OKUR-49.2%

Earnings Yield (TTM)

ANIX-10.5%

OKUR-60.3%

Dividend Yield (TTM)

ANIXN/A

OKURN/A

Rule of 40

ANIX0.0

OKUR0.0

EV/GP/RG

ANIXN/A

OKURN/A

Ticker research

View ANIX research View OKUR research

Metric	ANIX Anixa Biosciences Inc	OKUR Onkure Therapeutics Inc
Market & Valuation
Market Cap	$99M	$97M
Enterprise Value	$97M	$-69M
Price	$2.90	$2.41
P/E Ratio	N/A	N/A
P/S Ratio	488.35x	0.00x
EV/Sales	481.69x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	7.09x	0.60x
P/FCF Ratio	N/A	N/A
EV/FCF	-13.19x	1.44x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	71.59x
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	139.6%	100.0%
Profitability
Gross Margin (TTM)	100.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-10M	$-59M
FCF (TTM)	$-7M	$-48M
EPS (TTM)	-$0.30	-$1.18
ROE (TTM)	-7017.0%	-4902.0%
ROA (TTM)	-6780.0%	-4577.0%
ROIC (TTM)	-7017.0%	-4902.0%
Financial Health
Cash	$1M	$167M
Debt	$0	$0
Net Cash/Debt	$1M	$167M
Current Ratio (TTM)	8.55x	26.75x
Quick Ratio (TTM)	7.95x	26.55x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.47	0.19
52W Performance	-34.7%	-20.7%
YTD Performance	-8.2%	-18.6%
% from 52W High	-46.9%	-55.2%
% from 52W Low	25.0%	13.1%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-7.5%	-49.2%
Earnings Yield (TTM)	-10.5%	-60.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ANIX research	View OKUR research

Valuation

P/S Ratio

OKUR

0.00x

ANIX

488.35x

EV/FCF

ANIX

-13.19x

OKUR

1.44x

Growth & revenue

Forward Revenue Growth

ANIX

139.6%

OKUR

100.0%

Profitability & performance

Gross Margin

ANIX

100.0%

OKUR

0.0%

ROE

OKUR

-4902.0%

ANIX

-7017.0%

FCF Yield %

ANIX

-7.5%

OKUR

-49.2%

52-Week Performance

OKUR

-20.7%

ANIX

-34.7%

Detailed metrics comparison

ANIX

Anixa Biosciences Inc

OKUR

Onkure Therapeutics Inc

Market Cap

ANIX$99M

OKUR$97M

Enterprise Value

ANIX$97M

OKUR$-69M

Price

ANIX$2.90

OKUR$2.41

P/E Ratio

ANIXN/A

OKURN/A

P/S Ratio

ANIX488.35x

OKUR0.00x

EV/Sales

ANIX481.69x

OKUR0.00x

EV/EBITDA

ANIX0.00x

OKUR0.00x

P/B Ratio

ANIX7.09x

OKUR0.60x

P/FCF Ratio

ANIXN/A

OKURN/A

EV/FCF

ANIX-13.19x

OKUR1.44x

PEG Ratio

ANIXN/A

OKURN/A

Forward P/E (NTM)

ANIXN/A

OKURN/A

Forward P/S (NTM)

ANIXN/A

OKUR71.59x

Revenue (TTM)

ANIX$0

OKUR$0

Revenue Growth (YoY)

ANIXN/A

OKURN/A

Forward Rev Growth

ANIX139.6%

OKUR100.0%

Gross Margin (TTM)

ANIX100.0%

OKUR0.0%

Operating Margin (TTM)

ANIX0.0%

OKUR0.0%

EBITDA Margin (TTM)

ANIX0.0%

OKUR0.0%

Net Margin (TTM)

ANIX0.0%

OKUR0.0%

FCF Margin (TTM)

ANIXN/A

OKURN/A

Net Income (TTM)

ANIX$-10M

OKUR$-59M

FCF (TTM)

ANIX$-7M

OKUR$-48M

EPS (TTM)

ANIX-$0.30

OKUR-$1.18

ROE (TTM)

ANIX-7017.0%

OKUR-4902.0%

ROA (TTM)

ANIX-6780.0%

OKUR-4577.0%

ROIC (TTM)

ANIX-7017.0%

OKUR-4902.0%

Cash

ANIX$1M

OKUR$167M

Debt

ANIX$0

OKUR$0

Net Cash/Debt

ANIX$1M

OKUR$167M

Current Ratio (TTM)

ANIX8.55x

OKUR26.75x

Quick Ratio (TTM)

ANIX7.95x

OKUR26.55x

Debt/Equity (TTM)

ANIX0.00x

OKUR0.00x

Debt/Assets (TTM)

ANIX0.0%

OKUR0.0%

Interest Coverage (TTM)

ANIXN/A

OKURN/A

Net Debt/EBITDA (TTM)

ANIX0.00x

OKUR0.00x

Beta

ANIX0.47

OKUR0.19

52W Performance

ANIX-34.7%

OKUR-20.7%

YTD Performance

ANIX-8.2%

OKUR-18.6%

% from 52W High

ANIX-46.9%

OKUR-55.2%

% from 52W Low

ANIX25.0%

OKUR13.1%

Asset Turnover (TTM)

ANIX0.01x

OKUR0.00x

FCF Yield (TTM)

ANIX-7.5%

OKUR-49.2%

Earnings Yield (TTM)

ANIX-10.5%

OKUR-60.3%

Dividend Yield (TTM)

ANIXN/A

OKURN/A

Rule of 40

ANIX0.0

OKUR0.0

EV/GP/RG

ANIXN/A

OKURN/A

Ticker research

View ANIX research View OKUR research

Metric	ANIX Anixa Biosciences Inc	OKUR Onkure Therapeutics Inc
Market & Valuation
Market Cap	$99M	$97M
Enterprise Value	$97M	$-69M
Price	$2.90	$2.41
P/E Ratio	N/A	N/A
P/S Ratio	488.35x	0.00x
EV/Sales	481.69x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	7.09x	0.60x
P/FCF Ratio	N/A	N/A
EV/FCF	-13.19x	1.44x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	71.59x
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	139.6%	100.0%
Profitability
Gross Margin (TTM)	100.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-10M	$-59M
FCF (TTM)	$-7M	$-48M
EPS (TTM)	-$0.30	-$1.18
ROE (TTM)	-7017.0%	-4902.0%
ROA (TTM)	-6780.0%	-4577.0%
ROIC (TTM)	-7017.0%	-4902.0%
Financial Health
Cash	$1M	$167M
Debt	$0	$0
Net Cash/Debt	$1M	$167M
Current Ratio (TTM)	8.55x	26.75x
Quick Ratio (TTM)	7.95x	26.55x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.47	0.19
52W Performance	-34.7%	-20.7%
YTD Performance	-8.2%	-18.6%
% from 52W High	-46.9%	-55.2%
% from 52W Low	25.0%	13.1%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-7.5%	-49.2%
Earnings Yield (TTM)	-10.5%	-60.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ANIX research	View OKUR research